Vielight MIP 633-810 for Brain and Systemic Health
Vielight MIP 633-810 for Brain and Systemic Health
Vielight MIP 633-810 for Brain and Systemic Health
Vielight MIP 633-810 for Brain and Systemic Health
Vielight MIP 633-810 for Brain and Systemic Health
Vielight MIP 633-810 for Brain and Systemic Health
Berry Health UK

Vielight MIP 633-810 for Brain and Systemic Health

Regular price £279.00 £0.00 Unit price per
Tax included. Shipping calculated at checkout.

*** Special Order Item:  2-3 week delivery time from date of order ***

Recently released for 2023, this is the Vielight MIP 633-810. This completely unique device gives the possibility of using both the 810 (brain health) and 633 (systemic) applicators at the same time, or each one can be used individually.

The MIP 633-810 combo enables systemic and mild brain photobiomodulation.

The 633nm Red applicator is designed for systemic intranasal photobiomodulation. The 633nm applicator infuses the nasal capillaries with 633nm red light energy. This improves immunity, improves oxygenation and reduce inflammation.

The 810nm NIR applicator is designed for mild brain photobiomodulation. The 810nm applicator delivers NIR light energy to the olfactory bulb to improve cognitive function.

Memory and neuroplasticity have been linked to the olfactory system which is what this device targets.

The 810nm MIP applicator has approximately half the power density of the Vielight Neuro's 810nm applicator.
The Vielight Neuro's 810nm applicator is engineered to reach the olfactory bulb and ventromedial prefontal cortex.

Disclaimer: Vielight products are sold without any claims of efficacy or results. Always follow the instructions for each Vielight product carefully. 

---------------------------------------------------------------------------------

Published studies with Vielight technology

Alzheimers: 

https://www.vielight.com/wp-content/uploads/2020/01/Brain_Photobiomodulation_Alzheimers_Chao_2019.pdf

Parkinson's:

1. https://www.vielight.com/wp-content/uploads/2021/12/Improvements-in-clinical-signs-of-Parkinsons-disease-Liebert-2021-1.pdf

2.https://clinicaltrials.gov/ct2/show/NCT03551392

Autism Spectrum Disorder:

https://www.mdpi.com/2227-9067/9/5/755/htm


Share this Product

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)